About LongevityToday
The most comprehensive, real-time intelligence platform for longevity science — built by physicians who've spent their careers at the intersection of medicine and technology.
The science of human longevity is advancing faster than any individual — physician, researcher, or patient — can keep up with. New findings emerge daily from academic journals, clinical trials, podcasts, conference presentations, and drug approval pipelines. Most of it never reaches the people who need it most.
LongevityToday was built to change that. We use artificial intelligence to continuously monitor the world's leading sources of longevity research and deliver clear, accurate, and timely summaries — so you can stay current without spending hours digging through papers.
We believe that the gap between what science knows and what people understand and act on is one of the most consequential problems in medicine today. Closing that gap is our mission.
How We Cover the Field
Our AI continuously monitors and summarizes longevity research across a wide range of sources — all reviewed for accuracy and clinical relevance by our medical team.
Our Leadership
Founded and led by physicians with deep expertise in precision medicine, AI, and longevity science.
Donald E. Brown, MD
Founder & Chief Executive Officer
Don Brown is a physician, serial entrepreneur, and pioneer in the application of artificial intelligence to medicine. He earned his BS in physics and MD from Indiana University, and a master's degree in biotechnology from Johns Hopkins University — a combination that has guided his career-long conviction that software and biology, brought together, can fundamentally improve human health.
Over three decades, Don founded and scaled some of the most influential technology companies in the industry, including Interactive Intelligence, which he grew to a NASDAQ-listed company before its $1.4 billion acquisition by Genesys in 2016. He channeled that success into medicine, donating $30 million to establish the Brown Immunotherapy Center at the Indiana University School of Medicine. He went on to found LifeOmic, a precision medicine platform that partnered with Indiana University and the Regenstrief Institute to advance genomic medicine.
Don is currently the Founder and CEO of Bioscope.AI, a precision medicine company harnessing AI and multi-omics data to enable earlier disease detection and more effective prevention. LongevityToday is the natural extension of that work — making the leading edge of longevity science accessible to everyone.
Helen Messier, MD, PhD
Chief Medical Officer
Dr. Helen Messier is one of the foremost experts in longevity medicine, with a career spanning molecular immunology, genomics, multi-omics, and clinical precision medicine. She holds a BSc with Honors in Genetics and a PhD in Molecular Immunology from the University of Alberta, completed her post-doctoral training at the La Jolla Institute for Allergy and Immunology, and earned her MD from the University of Calgary. She is board certified in family medicine and a certified practitioner of the Institute for Functional Medicine.
Dr. Messier's career has placed her at the vanguard of longevity science at every stage. She served as Medical Director of Genomics at Human Longevity, Inc. — the pioneering company co-founded by J. Craig Venter — and was the founding Chief Medical Officer of Viome. Most recently, she served as Chief Medical and Science Officer at Fountain Life, where she led the integration of advanced diagnostics and biological age testing into personalized longevity programs for patients worldwide.
She is also the co-author of the Longevity Guidebook alongside Peter Diamandis, MD, bringing rigorous scientific perspective to the rapidly growing field of healthspan medicine. At LongevityToday, Dr. Messier provides clinical and scientific oversight of our AI summaries — ensuring that everything we publish meets the highest standards of accuracy and clinical relevance.
Janet Jones
Executive Editor
Janet Jones is the Executive Editor of LongevityToday.com, where she leads editorial strategy and oversees the site's mission to make the science of healthspan and lifespan extension accessible to a broad audience. With a keen eye for translating complex research into compelling, evidence-based content, Janet bridges the gap between cutting-edge longevity science and the everyday reader.
A graduate of The Ohio State University, Janet began her career in health and science journalism, quickly developing a reputation for rigorous reporting on topics ranging from metabolic health and genomics to the emerging field of precision longevity medicine. Before joining LongevityToday.com, she held editorial roles at several digital health publications, where she built and managed content teams focused on preventive medicine, nutrition, and biomarker-driven wellness.
Janet is particularly passionate about demystifying the multi-omic revolution — helping readers understand how advances in genomics, proteomics, epigenetics, and microbiome science are converging to reshape how we think about aging. She believes that longevity isn't a luxury topic but a public health imperative, and that great editorial work can empower people to take meaningful, informed action on their own healthspan.
When she's not editing, Janet can be found testing the latest wearable tech, experimenting with zone 2 training protocols, or diving into the latest preprints on senolytics. She lives in Columbus, Ohio, with her rescue dog, Darwin.
Our Editorial Standards
LongevityToday uses artificial intelligence to identify, process, and summarize research from hundreds of sources. This allows us to cover the field at a pace and breadth no human editorial team could match. But AI summaries are reviewed and validated by our medical leadership before publication.
We are committed to transparency about our methodology. Every summary links to its original source — whether a journal article, clinical trial registration, podcast episode, or news release. We do not take positions on treatments or products, and we do not accept advertising that influences editorial coverage.
If you believe a summary contains an error or misrepresents the underlying research, please contact us — we take corrections seriously and publish them prominently.